Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma-Reference-Cited by-同舟云学术

Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma

Published:2023 Issue:1 Volume:66 Page:56-66
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Suzuki Sayaka¹,Kuwamoto Satoshi²,Kawamura Koji¹,Matsushita Michiko³,Motokura Toru⁴,Hosoda Yuzuru¹,Maegaki Masaya¹,Hosoda Rina¹,Hara Kentaro¹,Umekita Yoshihisa²,Fukuda Tetsuya¹

Affiliation:

1. Department of Hematology, Tottori University Hospital, Yonago 683-8504, Japan

2. Department of Pathology, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

3. Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

4. Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/66/1/66_2023.02.007/_pdf

Reference34 articles.

1. 1. Al-Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol. 2015;90:790-5. PMID:26096944, DOI:10.1002/ajh.24086

2. 2. Liu Y, Barta SK. Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019;94:604-16. PMID:30859597, DOI:10.1002/ajh.25460

3. 3. Dang CV. MYC on the path to cancer. Cell. 2012;149:22-35. PMID:22464321, DOI:10.1016/j.cell.2012.03.003

4. 4. Riedell PA, Smith SM. Double hit and double expressors in lymphoma: definition and treatment. Cancer. 2018;124:4622-32. PMID:30252929, DOI:10.1002/cncr.31646

5. 5. International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987-94. PMID:8141877, DOI:10.1056/NEJM199309303291402